DASL-HiCaP的积极结果于#ESMO26上公布 @niazi_Dr7
👍在ADT + RT基础上加用#darolutamide治疗极高危#ProstateCancer患者，改善了
✅4年MFS（95% vs 88%；HR 0.42），✅延缓了CRPC（HR 0.22）
✅延长了后续接受激素治疗的时间（HR 0.36）
所有获益均具有临床意义，而OS数据尚不成熟。
#ProstateCancer #Radiationtherapy #UrologicOncology @oncodaily @OncoDailyGU @urotoday @ChrisSweens1
8 浏览 · 0 赞 · 0 转发 · 1 回复
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgPerioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgTarlatamab plus durvalumab (durva) vs durva as 1L maintenance (1LM) therapy following durva, platinum, and etoposide (1L durva + EP) in extensive-stage small cell lung cancer (ES-SCLC): Primary analysis of the phase 3 DeLLphi-305 trial
https://esmocongress.esmo.orgDarolutamide with androgen deprivation therapy (ADT) and definitive or salvage locoregional radiation therapy (RT) for localised, very high-risk prostate cancer: Interim analysis of an international, placebo-controlled, randomised phase 3 t
https://esmocongress.esmo.org- Sabine D. Brookman-May@brookmans76
While DASL-HiCaP reinforces ARPI intensification, important questions remain @Silke_Gillessen Why positive #STAMPEDE/#DASL-HiCaP, yet not #ENZARAD? Which high-risk patients benefit most? Primary vs salvage RT? And how does #PROTEUS reshape intensification around surgery? #Enzalutamide #Apalutamide #Darolutamide ❓Different risk definitions and primary vs salvage settings complicate comparisons. ❓Who truly needs ARPI intensification, and when? What is the additive role of #RadiationTherapy and #RadicalProstatectomy ❓With PROTEUS extending the discussion to prostatectomy, better patient selection and identifying the best prognostic and predictive biomarkers reflecting specific early/local/locally advanced indications remains key #ESMO26 #ProstateCancer #UrologicOncology @oncodaily @OncoDailyGU @urotoday
来源：Sabine D. Brookman-May · x.com